IgA Nephropathy
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
IgA nephropathy is a common glomerular disease that is an important cause of kidney failure. This review discusses advances in the therapy and understanding of the molecular basis of IgA nephropathy, a common glomerulopathy that not infrequently leads to kidney failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although IgA nephropathy is an immune-mediated disease, with mucosalderived IgA forming circulating immune complexes that deposit in the mesangium, 1 the role of immunosuppressive therapy remains controversial and is usually reserved for patients who do not respond to supportive measures.”
From A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy (2021) · cites this paper as [1]
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran, D. C., Coppo, R., Cook, H. T., Feehally, J., Roberts, I. S. D., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., et al. (2009) · Kidney International · doi:10.1038/ki.2009.243 · Cited by 1,235
Self-citationThe Pathophysiology of IgA Nephropathy
Suzuki, H., Kiryluk, K., Novak, J., Moldoveanu, Z., Herr, A. B., Renfrow, M. B., Wyatt, R. J., Scolari, F., Mestecky, J., Gharavi, A. G., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050464 · Cited by 910
Self-citationDonadio, J. V., & Grande, J. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020109 · Cited by 661
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
Reich, H. N., Troyanov, S. A. A., Scholey, J. W., & Cattran, D. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050526 · Cited by 639
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Gharavi, A. G., Kiryluk, K., Choi, M., Li, Y., Hou, P., Xie, J., Sanna-Cherchi, S., Men, C. J., Julian, B. A., Wyatt, R. J., et al. (2011) · Nature Genetics · doi:10.1038/ng.787 · Cited by 624
Self-citationRoos, A., Rastaldi, M. P., Calvaresi, N., Oortwijn, B. D., Schlagwein, N., van Gijlswijk-Janssen, D. J., Stahl, G. L., Matsushita, M., Fujita, T., van Kooten, C., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090923 · Cited by 450
Predicting renal outcome in IgA nephropathy.
Radford, M. G., Donadio, J. V., Bergstralh, E. J., & Grande, J. P. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v82199 · Cited by 440
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Moldoveanu, Z., Wyatt, R. J., Lee, J. Y., Tomana, M., Julian, B. A., Mestecky, J., Huang, W.-Q., Anreddy, S. R., Hall, S., Hastings, M. C., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002185 · Cited by 422
Self-citationLe, W., Liang, S., Hu, Y., Deng, K., Bao, H., Zeng, C., & Liu, Z. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr527 · Cited by 411
Kiryluk, K., Li, Y., Sanna-Cherchi, S., Rohanizadegan, M., Suzuki, H., Eitner, F., Snyder, H. J., Choi, M., Hou, P., Scolari, F., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002765 · Cited by 383
Self-citationMass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy
Hiki, Y., Odani, H., Takahashi, M., Yasuda, Y., Nishimoto, A., Iwase, H., Shinzato, T., Kobayashi, Y., & Maeda, K. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00591.x · Cited by 378
Predicting the Risk for Dialysis or Death in IgA Nephropathy
Berthoux, F., Mohey, H., Laurent, B., Mariat, C., Afiani, A., & Thibaudin, L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040355 · Cited by 361
Conley, M. E., Cooper, M. D., & Michael, A. F. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109998 · Cited by 331
Yu, X.-Q., Li, M., Zhang, H., Low, H.-Q., Wei, X., Wang, J.-Q., Sun, L.-D., Sim, K.-S., Li, Y., Foo, J.-N., et al. (2012) · Nature Genetics · doi:10.1038/ng.1047 · Cited by 312
Incidence of latent mesangial IgA deposition in renal allograft donors in Japan
Suzuki, K., Honda, K., Tanabe, K., Toma, H., Nihei, H., & Yamaguchi, Y. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.6s.2.x · Cited by 296
Moura, I. C., Centelles, M. N., Arcos-Fajardo, M., Malheiros, D. M., Collawn, J. F., Cooper, M. D., & Monteiro, R. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.417 · Cited by 293
Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
Gharavi, A. G., Moldoveanu, Z., Wyatt, R. J., Barker, C. V., Woodford, S. Y., Lifton, R. P., Mestecky, J., Novak, J., & Julian, B. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091052 · Cited by 284
Self-citationHLA Has Strongest Association with IgA Nephropathy in Genome-Wide Analysis
Feehally, J., Farrall, M., Boland, A., Gale, D. P., Gut, I., Heath, S., Kumar, A., Peden, J. F., Maxwell, P. H., Morris, D. L., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010076 · Cited by 281
Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy
ALLEN, A. C., HARPER, S. J., & FEEHALLY, J. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03724.x · Cited by 277
Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
Berthoux, F., Suzuki, H., Thibaudin, L., Yanagawa, H., Maillard, N., Mariat, C., Tomino, Y., Julian, B. A., & Novak, J. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010053 · Cited by 272
Self-citationUrine protein patterns can serve as diagnostic tools in patients with IgA nephropathy
Haubitz, M., Wittke, S., Weissinger, E. M., Walden, M., Rupprecht, H. D., Floege, J., Haller, H., & Mischak, H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00335.x · Cited by 223
Pathogenesis of IgA nephropathy
Lai, K. N. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.58 · Cited by 221
Renin Angiotensin System Blockade in Kidney Transplantation: A Systematic Review of the Evidence
Hiremath, S., Fergusson, D., Doucette, S., Mulay, A. V., & Knoll, G. A. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01928.x · Cited by 207
Coppo, R., Troyanov, S., Camilla, R., Hogg, R. J., Cattran, D. C., Terence Cook, H., Feehally, J., Roberts, I. S. D., Amore, A., Alpers, C. E., et al. (2010) · Kidney International · doi:10.1038/ki.2010.43 · Cited by 204
Self-citationA tricontinental view of IgA nephropathy
Geddes, C. C. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg207 · Cited by 193
Ponticelli, C., Traversi, L., Feliciani, A., Cesana, B. M., Banfi, G., & Tarantino, A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00006.x · Cited by 190
Toll-Like Receptor 9 Affects Severity of IgA Nephropathy
Suzuki, H., Suzuki, Y., Narita, I., Aizawa, M., Kihara, M., Yamanaka, T., Kanou, T., Tsukaguchi, H., Novak, J., Horikoshi, S., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121311 · Cited by 187
Prognostic indicators of IgA nephropathy in the Chinese—clinical and pathological perspectives
Li, P. K. T., Ho, K. K. L., Szeto, C. C., Yu, L., & Lai, F. M. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.1.64 · Cited by 170
Shi, Y., Chen, W., Jalal, D., Li, Z., Chen, W., Mao, H., Yang, Q., Johnson, R. J., & Yu, X. (2012) · Kidney and Blood Pressure Research · doi:10.1159/000331453 · Cited by 166
Kokubo, T., Hiki, Y., Iwase, H., Tanaka, A., Toma, K., Hotta, K., & Kobayashi, Y. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9112048 · Cited by 166
An update on the pathogenesis and treatment of IgA nephropathy
Boyd, J. K., Cheung, C. K., Molyneux, K., Feehally, J., & Barratt, J. (2012) · Kidney International · doi:10.1038/ki.2011.501 · Cited by 164
The Use of the Oxford Classification of IgA Nephropathy to Predict Renal Survival
Alamartine, E., Sauron, C., Laurent, B., Sury, A., Seffert, A., & Mariat, C. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01170211 · Cited by 162
Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA?
Nair, R., & Walker, P. D. (2006) · Kidney International · doi:10.1038/sj.ki.5000292 · Cited by 161
Henoch-Schönlein Purpura Nephritis: Pathophysiology, Treatment, and Future Strategy
Davin, J.-C. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06710810 · Cited by 161
A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy
Karoui, K. E., Hill, G. S., Karras, A., Jacquot, C., Moulonguet, L., KOURILSKY, O., Frémeaux‐Bacchi, V., Delahousse, M., Huyen, J. D. V., Loupy, A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111130 · Cited by 153
Regression of IgA nephropathy: A repeat biopsy study
Hotta, O., Furuta, T., Chiba, S., Tomioka, S., & Taguma, Y. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31399 · Cited by 148
Glycosylation of IgA1 and pathogenesis of IgA nephropathy
Novák, J., Julian, B. A., Mestecky, J. F., & Renfrow, M. B. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0306-z · Cited by 145
Self-citationThe impact of sex in primary glomerulonephritis
Cattran, D. C., Reich, H. N., Beanlands, H. J., Miller, J., Scholey, J. W., Troyanov, S., & for the Genes, G. A. G. G. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm919 · Cited by 145
IgA nephropathy: Long-term prognosis for pediatric patients
Wyatt, R. J., Kritchevsky, S. B., Woodford, S. Y., Miller, P. M., Roy, S., Holland, N. H., Jackson, E., & Bishof, N. A. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70027-7 · Cited by 138
Self-citationLai, K. N., Leung, J. C. K., Chan, L. Y. Y., Saleem, M. A., Mathieson, P. W., Lai, F. M., & Tang, S. C. W. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00423.2007 · Cited by 136
O-Glycosylation of Serum IgA1 Antibodies against Mucosal and Systemic Antigens in IgA Nephropathy
Smith, A. C., Molyneux, K., Feehally, J., & Barratt, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060658 · Cited by 135
Steroids and Recurrent IgA Nephropathy After Kidney Transplantation
Clayton, P. A., McDonald, S. P., & Chadban, S. J. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03667.x · Cited by 129
Mesangial C4d deposition: a new prognostic factor in IgA nephropathy
Espinosa, M., Ortega, R., Gómez-Carrasco, J. M., López‐Rubio, F., López-Andréu, M., López‐Oliva, M. O., & Aljama, P. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn563 · Cited by 129
Oxidative Stress and Galactose-Deficient IgA1 as Markers of Progression in IgA Nephropathy
Camilla, R., Suzuki, H., Daprà, V., Loiacono, E., Peruzzi, L., Amore, A., Ghiggeri, G. M., Mazzucco, G., Scolari, F., Gharavi, A. G., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11571210 · Cited by 126
Self-citationActivated complement C3: A potentially novel predictor of progressive IgA nephropathy
Zwirner, J., Burg, M., Schulze, M. B., Brunkhorst, R. R., Götze, O., Km, K., & Floege, J. (1997) · Kidney International · doi:10.1038/ki.1997.171 · Cited by 120
Bellur, S. S., Troyanov, S., Cook, H. T., Roberts, I. S. D., & on behalf of a Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq812 · Cited by 120
Torres, D. D., Rossini, M., Manno, C., Mattace-Raso, F. U. S., D’Altri, C., Ranieri, E., Pontrelli, P., Grandaliano, G., Gesualdo, L., & Schena, F. P. (2007) · Kidney International · doi:10.1038/sj.ki.5002621 · Cited by 119
Chapter 10: Immunoglobulin A nephropathy
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.23 · Cited by 119
Recurrence of IgA Nephropathy in Renal Allografts
Berger, J. (1988) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(88)80027-1 · Cited by 112
Wyatt, R. J., Julian, B. A., Baehler, R. W., Stafford, C. C., McMorrow, R. G., Ferguson, T., Jackson, E., Woodford, S. Y., Miller, P. M., & Kritchevsky, S. B. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v95853 · Cited by 105
Self-citationBerthoux, F. C., Deeb, S. E., Mariat, C., Diconne, É., Laurent, B., & Thibaudin, L. (2008) · Transplantation · doi:10.1097/tp.0b013e3181705ad4 · Cited by 102
LV, J., ZHANG, H., ZHOU, Y., LI, G., ZOU, W., & WANG, H. (2008) · Nephrology · doi:10.1111/j.1440-1797.2007.00898.x · Cited by 100
Genetic studies of IgA nephropathy: past, present, and future
Kiryluk, K., Julian, B. A., Wyatt, R. J., Scolari, F., Zhang, H., Novák, J., & Gharavi, A. G. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1500-7 · Cited by 100
Self-citationVuong, M. T., Hahn‐Zoric, M., Lundberg, S. G. G., Gunnarsson, I., van Kooten, C., Wramner, L., Seddighzadeh, M., Fernström, A., Hanson, L. Å., Lieu, T. D., et al. (2010) · Kidney International · doi:10.1038/ki.2010.314 · Cited by 97
Asao, R., Asanuma, K., Kodama, F., Akiba-Takagi, M., Hosoe-Nagai, Y., Seki, T., Takeda, Y., Ohsawa, I., Mano, S., Matsuoka, K., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08110811 · Cited by 93
FGF23, Albuminuria, and Disease Progression in Patients with Chronic IgA Nephropathy
Lundberg, S. G. G., Qureshi, A. R., Olivecrona, S., Gunnarsson, I., Jacobson, S. H., & Larsson, T. E. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10331011 · Cited by 84
Electrophoretic methods for analysis of urinary polypeptides in IgA‐associated renal diseases
Julian, B. A., Wittke, S., Novák, J., Good, D. M., Coon, J. J., Kellmann, M., Zürbig, P., Schiffer, E., Haubitz, M., Moldoveanu, Z., et al. (2007) · Electrophoresis · doi:10.1002/elps.200700237 · Cited by 82
Self-citationLong-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study
Ronkainen, J., Ala‐Houhala, M., Autio‐Harmainen, H., Jahnukainen, T., Koskimies, O., Merenmies, J. M., Mustonen, J. T., Örmälä, T., Turtinen, J. K., & Nuutinen, M. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0163-x · Cited by 81
Galactose-Deficient IgA1 in African Americans with IgA Nephropathy
Hastings, M. C., Moldoveanu, Z., Julian, B. A., Novák, J., Sanders, J. T., McGlothan, K. R., Gharavi, A. G., & Wyatt, R. J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03270410 · Cited by 81
Self-citationUrine protein profile of IgA nephropathy patients may predict the response to ACE‐inhibitor therapy
Rocchetti, M. T., Centra, M., Papale, M., Bortone, G., Palermo, C., Centonze, D., Ranieri, E., Paolo, S. D., & Gesualdo, L. (2007) · PROTEOMICS · doi:10.1002/pmic.200700492 · Cited by 80
Lin, X., Ding, J., Zhu, L., Shi, S., Jiang, L., Zhao, M., & Zhang, H. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp294 · Cited by 75
Kataoka, H., Ohara, M., Shibui, K., Sato, M., Suzuki, T., Amemiya, N., Watanabe, Y., Honda, K., Mochizuki, T., & Nitta, K. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0613-7 · Cited by 73
Incidence of pediatric IgA nephropathy
Utsunomiya, Y., Koda, T., Kado, T., Okada, S.-I., Hayashi, A., Kanzaki, S., Kasagi, T., Hayashibara, H., & Okasora, T. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1127-z · Cited by 67
Wada, Y., Ogata, E., Takeshige, Y., Takeshima, A., Yoshida, N., Yamamoto, M., Ito, H., & Kinugasa, E. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0660-0 · Cited by 57
Barratt, J., Eitner, F., Feehally, J., & Floege, J. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp441 · Cited by 55
Liu, L.-L., Jiang, Y., Wang, L.-N., & Liu, N. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04604.x · Cited by 50
Amore, A., Conti, G., Cirina, P., Peruzzi, L., Alpa, M., Bussolino, F., & Coppo, R. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.19840 · Cited by 46
Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy
Miyamoto, H., Yoshioka, K., Takemura, T., Akano, N., & Maki, S. (1988) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00844284 · Cited by 39
IgA Nephropathy: Progress Before and Since Berger
Feehally, J., & Cameron, J. S. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.03.024 · Cited by 36
Validation of the Toronto Formula to Predict Progression in IgA Nephropathy
Mackinnon, B., Fraser, E. P., Cattran, D., Fox, J. G., & Geddes, C. (2008) · Nephron Clinical Practice · doi:10.1159/000145458 · Cited by 31
Kaneko, Y., Otsuka, T., Tsuchida, Y., Gejyo, F., & Narita, I. (2012) · International Immunology · doi:10.1093/intimm/dxr125 · Cited by 30
Inherited IgA glycosylation pattern in IgA nephropathy and HSP nephritis: where do we go next?
Boyd, J., & Barratt, J. (2011) · Kidney International · doi:10.1038/ki.2011.83 · Cited by 23
Pre‐transplant course and risk of kidney transplant failure in IgA nephropathy patients
Bjørneklett, R. O., Vikse, B. E., Smerud, H. K., Bostad, L. H., Leivestad, T., Hartmann, A., & Iversen, B. M. (2011) · Clinical Transplantation · doi:10.1111/j.1399-0012.2011.01424.x · Cited by 11
Fischer, D., Nissel, R., Puhlmann, A., Mitzner, A., Tiess, M., Schmidt, R. E., & Haffner, D. (2009) · Clinical Nephrology · doi:10.5414/cnp72344 · Cited by 9
Research works printed but not linked: 8
- D'Amico G, 1987, Q J Med, 64, 709
- Haas M. IgA nephropathy and Henoch-Schoenlein purpura nephritis. In: Jennette JC, Olsen JL, Schwartz MM, Silva FG, eds. Heptinstall's pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2007:423-86.
- 10.1046/j.1523-1755.2001.0590031077.x · doi:10.1046/j.1523-1755.2001.0590031077.x · Paper page
- Silva FG, 1982, Transplantation, 33, 241
- Odani H, 2010, J Nephrol, 23, 70
- Suzuki H, 2009, J Clin Invest, 119, 1668
- Peters HP, 2009, Neth J Med, 67, 54
- D'Amico G, 1986, Q J Med, 59, 363
Cited by
Intensive supportive care plus immunosuppression in IgA nephropathy
Rauen, T., Eitner, F., Fitzner, C., Sommerer, C., Zeier, M., Otte, B., Panzer, U., Peters, H., Benck, U., Mertens, P. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415463 · Cited by 726
Kiryluk, K., Li, Y., Scolari, F., Sanna-Cherchi, S., Choi, M., Verbitsky, M., Fasel, D., Lata, S., Prakash, S., Shapiro, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.3118 · Cited by 628
Self-citationLv, J., Zhang, H., Wong, M. G., Jardine, M. J., Hladunewich, M., Jha, V., Monaghan, H., Zhao, M., Barbour, S., Reich, H., et al. (2017) · JAMA · doi:10.1001/jama.2017.9362 · Cited by 540
Wheeler, D. C., Toto, R. D., Stefánsson, B. V., Jongs, N., Chertow, G. M., Greene, T., Hou, F. F., McMurray, J. J. V., Pecoits-Filho, R., Correa-Rotter, R., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.03.033 · Cited by 420
“201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 I gA nephropathy is the most common primary glomerular disease worldwide.(1) Despite advances in our understanding of its pathogenesis, treatment strategies have changed little over the last 2 or 3 decades.”
BackgroundFellström, B. C., Barratt, J., Cook, H., Coppo, R., Feehally, J., de Fijter, J. W., Floege, J., Hetzel, G., Jardine, A. G., Locatelli, F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30550-0 · Cited by 414
Metadata
- Authors
- Wyatt, R. J., & Julian, B. A.
- Affiliations
- University of Tennessee Health Science Center (US)
- University of Alabama at Birmingham (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-06-20
- Volume
- 368
- Issue
- 25
- Pages
- 2402-2414
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4247172809
- Cited by
- 1,222
- References
- 75
- Citations by year
- 2026: 97 · 2025: 98 · 2024: 118 · 2023: 122 · 2022: 109 · 2021: 110 · 2020: 104 · 2019: 91 · 2018: 76 · 2017: 85 · 2016: 77 · 2015: 69 · 2014: 58 · 2013: 8
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- IgA nephropathy, glomerular disease, renal failure, IgA, molecular pathogenesis, treatment
- MeSH terms
- Angiotensin-Converting Enzyme Inhibitors, Glomerulonephritis, IGA, Humans, Immunoglobulin A, Molecular Structure, Biomarkers, Angiotensin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.